TRVI   $3.15  -5.69% Market Open

Trevi Therapeutics Inc
Total Cash 69.50M
totalCashPerShare 0.957
EBITDA -43.03M
Total Debt 1.19M
quickRatio 10.293
currentRatio 10.683
Total Revenue
debtToEquity 1.803
Revenue/Share
ROA -0.30875
ROE -0.48091
grossProfits
freeCashflow -19.17M
operatingCashflow -32.79M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 158.18M
forwardPE -6.9791665
floatShares 43.50M
sharesOutstanding 72.59M
sharesShort 1.51M
sharesShortPriorMonth 1.55M
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.77%
Short Ratio help_outline 3.46%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 0.912
Price To Book help_outline 3.67
earningsQuarterlyGrowth
netIncomeToCommon -38.77M
trailingEps -0.38%
forwardEps -0.48%
enterpriseToEbitda -3.68
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.12 3Q 2024
institutionsCount 107
lastUpdated Oct. 22, 2024, 12:19 a.m.